Aurobindo to acquire additional 20% stake in Chinese JV for $5 million

Aurobindo Pharma volition get an further 20% involvement successful inhalation products manufacturing associated task Luoxin Aurovitas successful China from the JV spouse for $5.125 million.

Besides the 20% involvement that is expected to beryllium acquired wrong adjacent 3 months, it volition person the close to get equilibrium 50% involvement by December 2029 astatine an agreed terms of $18.86 mn taxable to definite presumption and conditions.

The Hyderabad-based drugmaker successful a filing connected Tuesday said subsidiary Helix Healthcare and Chinese spouse Shandong Luoxin successful the 30:70 associated task entered into a binding statement connected December 22 for the involvement acquisition. On the nonsubjective down acquiring further stake, Aurobindo Pharma said it is to grow the manufacturing to economies of standard by adding 2 precocious velocity lines and cater marketplace demand.

Luoxin Aurovitas was acceptable up arsenic a JV for manufacturing inhalation products successful China connected March 25, 2019. Its existent nett worthy is $15.29 million.